Literature DB >> 2476706

Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.

F M Foss1, A Veillette, O Sartor, N Rosen, J B Bolen.   

Abstract

The effects of butyrate-mediated differentiation of human colon carcinoma cells on the expression of src-related tyrosine protein kinases were analyzed. The results demonstrate that treatment of a variety of colon carcinoma cell lines with 2 mM sodium butyrate resulted in diminished population doubling rates, altered morphology, decreased anchorage-independent growth, and increased expression of colon epithelial differentiation marker enzymes such as alkaline phosphatase. In butyrate-treated cells, significantly diminished protein kinase activities and abundance of pp60c-src and p56lck were found to parallel the butyrate-induced phenotypic alterations. For the lck gene, the decreased levels in p56lck abundance were found to coincide with diminished levels of steady-state lck mRNAs. In contrast, treatments which arrested the growth of the colon carcinoma cells without inducing differentiation had no effect on the level of expression of these proteins. Furthermore, colon carcinoma cell lines which were found to be resistant to butyrate-induced differentiation showed no change in the kinase activity or abundance of either protein following butyrate treatment. These results indicate that the expression of several src-related kinases in human colon carcinoma can be influenced by the differentiation state of the cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476706

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  10 in total

1.  Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent.

Authors:  V V Ogryzko; T H Hirai; V R Russanova; D A Barbie; B H Howard
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 2.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells.

Authors:  C Domon-Dell; Q Wang; S Kim; M Kedinger; B M Evers; J-N Freund
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Dissociation of retinoblastoma gene protein hyperphosphorylation and commitment to enter S phase.

Authors:  V V Ogryzko; T H Hirai; C E Shih; B H Howard
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype.

Authors:  Mònica Comalada; Elvira Bailón; Oscar de Haro; Federico Lara-Villoslada; Jordi Xaus; Antonio Zarzuelo; Julio Gálvez
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-17       Impact factor: 4.553

Review 6.  Butyrate and the colonocyte. Implications for neoplasia.

Authors:  O C Velázquez; H M Lederer; J L Rombeau
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

7.  Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer.

Authors:  M R Clausen; H Bonnén; P B Mortensen
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

8.  Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

Authors:  C A Cartwright; C A Coad; B M Egbert
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  c-src structure in human cancers with elevated pp60c-src activity.

Authors:  P Wang; F Fromowitz; M Koslow; N Hagag; B Johnson; M Viola
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

Review 10.  Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications.

Authors:  Wook Jin
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.